Citadel Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $891K | Sell |
60,100
-26,400
| -31% | -$386K | ﹤0.01% | 7927 |
|
|
2025
Q4 | $1.38M | Sell |
86,500
-51,500
| -37% | -$730K | ﹤0.01% | 6701 |
|
|
2025
Q3 | $1.52M | Buy |
138,000
+3,800
| +3% | +$41.5K | ﹤0.01% | 6637 |
|
|
2025
Q2 | $1.14M | Buy |
134,200
+26,600
| +25% | +$213K | ﹤0.01% | 6797 |
|
|
2025
Q1 | $865K | Sell |
107,600
-30,400
| -22% | -$246K | ﹤0.01% | 7285 |
|
|
2024
Q4 | $1.24M | Sell |
138,000
-3,500
| -2% | -$28.6K | ﹤0.01% | 6580 |
|
|
2024
Q3 | $1.04M | Buy |
141,500
+30,700
| +28% | +$190K | ﹤0.01% | 6798 |
|
|
2024
Q2 | $633K | Sell |
110,800
-24,300
| -18% | -$128K | ﹤0.01% | 7562 |
|
|
2024
Q1 | $677K | Sell |
135,100
-478,800
| -78% | -$3.25M | ﹤0.01% | 7735 |
|
|
2023
Q4 | $5.52M | Buy |
613,900
+99,900
| +19% | +$823K | ﹤0.01% | 3641 |
|
|
2023
Q3 | $3.99M | Buy |
514,000
+73,200
| +17% | +$716K | ﹤0.01% | 4009 |
|
|
2023
Q2 | $4.27M | Sell |
440,800
-336,500
| -43% | -$3.49M | ﹤0.01% | 3890 |
|
|
2023
Q1 | $8.52M | Buy |
777,300
+38,700
| +5% | +$341K | ﹤0.01% | 3016 |
|
|
2022
Q4 | $3.19M | Sell |
738,600
-61,100
| -8% | -$355K | ﹤0.01% | 4656 |
|
|
2022
Q3 | $6.01M | Sell |
799,700
-144,500
| -15% | -$1.25M | ﹤0.01% | 3562 |
|
|
2022
Q2 | $9.49M | Sell |
944,200
-272,900
| -22% | -$3.05M | ﹤0.01% | 2755 |
|
|
2022
Q1 | $15.1M | Sell |
1,217,100
-475,200
| -28% | -$7.34M | ﹤0.01% | 2361 |
|
|
2021
Q4 | $38.7M | Buy |
1,692,300
+770,000
| +83% | +$18.2M | 0.01% | 1378 |
|
|
2021
Q3 | $20.4M | Buy |
922,300
+493,600
| +115% | +$7.83M | ﹤0.01% | 1961 |
|
|
2021
Q2 | $5.56M | Sell |
428,700
-38,800
| -8% | -$494K | ﹤0.01% | 4211 |
|
|
2021
Q1 | $6.07M | Buy |
467,500
+50,900
| +12% | +$739K | ﹤0.01% | 3848 |
|
|
2020
Q4 | $5.76M | Buy |
416,600
+185,000
| +80% | +$2.69M | ﹤0.01% | 3448 |
|
|
2020
Q3 | $3.41M | Buy |
231,600
+78,100
| +51% | +$1.13M | ﹤0.01% | 3763 |
|
|
2020
Q2 | $2.49M | Sell |
153,500
-221,600
| -59% | -$3.55M | ﹤0.01% | 4176 |
|
|
2020
Q1 | $5.44M | Sell |
375,100
-232,200
| -38% | -$4.1M | ﹤0.01% | 2591 |
|
|
2019
Q4 | $12.3M | Buy |
607,300
+518,700
| +585% | +$4.78M | 0.01% | 1982 |
|
|
2019
Q3 | $473K | Buy |
88,600
+28,900
| +48% | +$175K | ﹤0.01% | 6851 |
|
|
2019
Q2 | $393K | Buy |
59,700
+2,900
| +5% | +$18.5K | ﹤0.01% | 7171 |
|
|
2019
Q1 | $369K | Buy |
+56,800
| New | +$377K | ﹤0.01% | 7295 |
|
|
2018
Q3 | – | Sell |
-25,700
| Closed | -$145K | – | 9185 |
|
|
2018
Q2 | $145K | Sell |
25,700
-900
| -3% | -$5.02K | ﹤0.01% | 8085 |
|
|
2018
Q1 | $138K | Buy |
26,600
+13,400
| +102% | +$71.7K | ﹤0.01% | 7586 |
|
|
2017
Q4 | $60K | Sell |
13,200
-77,900
| -86% | -$432K | ﹤0.01% | 7573 |
|
|
2017
Q3 | $571K | Sell |
91,100
-28,000
| -24% | -$177K | ﹤0.01% | 5128 |
|
|
2017
Q2 | $730K | Buy |
119,100
+84,300
| +242% | +$568K | ﹤0.01% | 4572 |
|
|
2017
Q1 | $255K | Buy |
+34,800
| New | +$161K | ﹤0.01% | 6122 |
|
Other funds holding AUPH
TCM
NMC
